Key result
The STARFlex device for atrial septal defect closure was associated with significantly lower rates of residual shunts and arm fractures compared to the CardioSEAL device.
Why the study?
Does the STARFlex device improve closure rates and reduce device-related complications compared to the CardioSEAL device in patients undergoing transcatheter ASD closure?
Cohort (n=117)
Does the STARFlex device improve closure rates and reduce device-related complications compared to the CardioSEAL device in patients undergoing transcatheter ASD closure?
The STARFlex device provides superior early and follow-up results for transcatheter ASD closure compared to the CardioSEAL device, primarily due to reduced residual shunting and fewer device arm fractures.
Answers are grounded in this paper and cite their sources.
May support STARFlex preference for ASD closure; leaves open confirmation in randomized trials.
BACKGROUND: The STARFlex (SF) device is a CardioSEAL (CS) double-umbrella device that has been modified by the addition of a self-centering mechanism comprised of nitinol springs connected between the two umbrellas and a flexible core wire with a pin-pivoting connection. This paper compares the results of atrial septal defect (ASD) closure with CardioSEAL and STARFlex devices. PATIENTS AND METHODS: Between December 1996 and March 2000, 117 patients underwent ASD closure with CardioSEAL (n = 79) and STARFlex (n = 38). The mean age (17 years), weight (49 kg), and ASD size (15 mm) were similar in the two groups. The procedures were performed under general anesthesia with both fluoroscopic and transesophageal echocardiographic monitoring. IMMEDIATE RESULTS: The devices were successfully implanted in all patients. Ten patients had multiple ASDs. A single device was used in four patients (CardioSEAL in three, STARFlex in one), while a simultaneous placement of two CardioSEAL (one patient) or two STARFlex (five patients) were performed in six patients. The results are summarized as follows: [table: see text] Follow-Up Results: On follow-up clinical exam, electrocardiograms, chest X-rays, and echocardiograms were obtained at 1, 6, and 12 months. [table: see text] During follow-up there were no deaths, endocarditis, rhythm disturbances, or other complications. Arm fractures were observed almost exclusively with large CardioSEAL devices (40 mm, less frequently with 33 mm), and only in one 33-mm STARFlex device. There were no clinical complications related to fractures. CONCLUSIONS: The STARFlex device seems to offer better results than the CardioSEAL, with significantly lower rates of residual shunts and arm fractures.
No takes yet. Share an insight, caveat, or question.
Carminati et al. (2001) conducted a cohort in atrial septal defect (n=117). STARFlex device vs. CardioSEAL device was evaluated on residual shunts and arm fractures. The STARFlex device for atrial septal defect closure was associated with significantly lower rates of residual shunts and arm fractures compared to the CardioSEAL device.
Synapse has enriched 10 related papers. Consider them for comparative context: